India to Guatemala: Sunitinib Export Trade Route
India has recorded 4 verified shipments of Sunitinib exported to Guatemala, representing a combined trade value of $527.0K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $131.8K USD. The leading Indian exporter is CAPLIN POINT LABORATORIES LIMITED, which accounts for 100% of total export value with 4 shipments worth $527.0K USD. On the buying side, NUEVOS ETICOS NEOETHICALS S A is the largest importer in Guatemala with $527.0K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Guatemala Sunitinib corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $527.0K USD. The route is dominated by CAPLIN POINT LABORATORIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's sunitinib manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $131.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with sunitinib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 10.1%, placing it at rank #12 among India's top sunitinib export destinations globally.
On the import side, key buyers of Indian sunitinib in Guatemala include NUEVOS ETICOS NEOETHICALS S A. NUEVOS ETICOS NEOETHICALS S A is the single largest importer with 4 shipments valued at $527.0K USD.
Route Characteristics
- Average transit25 days
